- Home
- PHAT vs MCBS Comparison
PHAT vs MCBS Comparison
Compare PHAT & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- MCBS
- Stock Information
- Founded
- PHAT 2018
- MCBS 2006
- Country
- PHAT United States
- MCBS United States
- Employees
- PHAT N/A
- MCBS N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- MCBS Major Banks
- Sector
- PHAT Health Care
- MCBS Finance
- Exchange
- PHAT Nasdaq
- MCBS Nasdaq
- Market Cap
- PHAT 640.9M
- MCBS 739.2M
- IPO Year
- PHAT 2019
- MCBS 2019
- Fundamental
- Price
- PHAT $8.35
- MCBS $26.90
- Analyst Decision
- PHAT Strong Buy
- MCBS Hold
- Analyst Count
- PHAT 5
- MCBS 1
- Target Price
- PHAT $16.40
- MCBS $34.00
- AVG Volume (30 Days)
- PHAT 937.1K
- MCBS 39.1K
- Earning Date
- PHAT 08-07-2025
- MCBS 07-18-2025
- Dividend Yield
- PHAT N/A
- MCBS 3.42%
- EPS Growth
- PHAT N/A
- MCBS 20.64
- EPS
- PHAT N/A
- MCBS 2.57
- Revenue
- PHAT $81,859,000.00
- MCBS $145,158,000.00
- Revenue This Year
- PHAT $195.03
- MCBS $18.90
- Revenue Next Year
- PHAT $106.77
- MCBS $30.18
- P/E Ratio
- PHAT N/A
- MCBS $10.47
- Revenue Growth
- PHAT 3055.70
- MCBS 14.81
- 52 Week Low
- PHAT $2.21
- MCBS $24.24
- 52 Week High
- PHAT $19.71
- MCBS $36.15
- Technical
- Relative Strength Index (RSI)
- PHAT 47.45
- MCBS 33.94
- Support Level
- PHAT $7.61
- MCBS $28.82
- Resistance Level
- PHAT $9.23
- MCBS $30.06
- Average True Range (ATR)
- PHAT 0.66
- MCBS 0.91
- MACD
- PHAT -0.08
- MCBS -0.35
- Stochastic Oscillator
- PHAT 30.64
- MCBS 3.70
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.